scholarly journals Two-year prognosis of patients hospitalized with decompensated heart failure in a district general hospital

2021 ◽  
Author(s):  
Małgorzata Dobrowolska ◽  
Paweł Miękus ◽  
Michał Świątczak ◽  
Grzegorz Raczak ◽  
Ludmiła Daniłowicz-Szymanowicz
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Hwei Sung Ling ◽  
Bui Khiong Chung ◽  
Pin Fen Chua ◽  
Kai Xin Gan ◽  
Wai Leng Ho ◽  
...  

Abstract Background Data on clinical characteristics of acute decompensated heart failure (ADHF) in Malaysia especially in East Malaysia is lacking. Methods This is a prospective observational study in Sarawak General Hospital, Medical Department, from October 2017 to September 2018. Patients with primary admission diagnosis of ADHF were recruited and followed up for 90 days. Data on patient’s characteristics, precipitating factors, medications and short-term clinical outcomes were recorded. Results Majority of the patients were classified in lower socioeconomic group and the mean age was 59 years old. Hypertension, diabetes mellitus and dyslipidaemia were the common underlying comorbidities. Heart failure with ischemic aetiology was the commonest ADHF admission precipitating factor. 48.6% of patients were having preserved ejection fraction HF and the median NT-ProBNP level was 4230 pg/mL. Prescription rate of the evidence-based heart failure medication was low. The in-patient mortality and the average length of hospital stay were 7.5% and 5 days respectively. 43% of patients required either ICU care or advanced cardiopulmonary support. The 30-day, 90-day mortality and readmission rate were 13.1%, 11.2%, 16.8% and 14% respectively. Conclusion Comparing with the HF data from West and Asia Pacific, the short-term mortality and readmission rate were high among the ADHF patients in our study cohort. Maladaptation to evidence-based HF prescription and the higher prevalence of cardiovascular risk factors in younger patients were among the possible issues to be addressed to improve the HF outcome in regions with similar socioeconomic background.


Heart ◽  
2016 ◽  
Vol 102 (Suppl 6) ◽  
pp. A12.1-A12
Author(s):  
Clare Coyle ◽  
Baltazar Nyathi ◽  
Simon Woldman ◽  
Mihir Sanghvi ◽  
Lindsey Iles ◽  
...  

QJM ◽  
2004 ◽  
Vol 97 (3) ◽  
pp. 133-139 ◽  
Author(s):  
P.A. Mehta ◽  
S. McDonagh ◽  
P.A. Poole-Wilson ◽  
R. Grocott-Mason ◽  
S.W. Dubrey

2019 ◽  
Author(s):  
Hannah Sinclair ◽  
Melanie Ackrill ◽  
Hiliary Holdsworth ◽  
Chris Chase ◽  
Maxine Guillen ◽  
...  

2020 ◽  
Vol 15 (8) ◽  
pp. 1-9
Author(s):  
Tim Chester ◽  
Joanne Passmore

The use of brain natriuretic peptide biomarkers is often cited in guidelines for heart failure as part of diagnostic pathways for patients with suspected heart failure. The biomarker result helps clinicians to decide whether a patient goes on for transthoracic echocardiography. This article reviews the use and usefulness of these biomarkers in a district general hospital and its impact on patients admitted with suspected heart failure. For those considering its use, this paper may offer some insights into how to implement such tests for acute inpatients.


Sign in / Sign up

Export Citation Format

Share Document